Coronavirus: Thread

[grarpamp]

> Pfizer, Moderna Jabs Cause Heart Inflammation In Some Young Men, CDC Finds
> https://www.reuters.com/world/us/cdc-heart-inflammation-cases-ages-16-24-higher-than-expected-after-mrna-covid-19-2021-06-10/


Sweden, Denmark Restrict Use Of Moderna Jab Over Risk Of Heart
Inflammation, Other Side Effects

https://www.washingtonpost.com/health/2021/08/19/moderna-vaccine-myocarditis/
https://twitter.com/SueC00K/status/1428631367399755782
https://www.reuters.com/world/middle-east/israel-sees-probable-link-between-pfizer-vaccine-small-number-myocarditis-cases-2021-06-01/
https://www.nature.com/articles/d41586-021-01442-9
https://jamanetwork.com/journals/jamacardiology/fullarticle/2781601
https://www.theepochtimes.com/mkt_breakingnews/fda-adds-warning-about-heart-inflammation-to-covid-19-mrna-vaccines_3876245.html
https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-june-25-2021
https://www.theepochtimes.com/giving-the-right-name-to-the-virus-causing-a-worldwide-pandemic-2_3277200.html
https://www.theepochtimes.com/mkt_app/cdc-finds-more-cases-of-heart-inflammation-than-expected-connected-to-covid-19-vaccines_3870915.html


As Dr. Fauci and other top public health officials in the US (along
with their Big Pharma allies) continue to push for mandatory
vaccinations for increasingly younger patients which could soon extend
to babies as young as 6 months), health authorities in Sweden - which
saw fewer excess deaths than its neighbors despite avoiding lockdowns
during the initial wave of the COVID pandemic - have decided to stop
giving the Moderna jab to anyone born in 1991 or later.

The Swedes were joined a few hours later by health authorities in
Denmark, who suspended use of Moderna's jab in patients aged 18 and
younger.

For context, the Modern jabs were found to be more likely to cause
dangerous inflammation in the heart by at least one study - to
patients born in 1991 (meaning anyone 30 and younger).

    “The Swedish Public Health Agency has decided to suspend the use
of Moderna’s vaccine Spikevax, for everyone born 1991 and later, for
precautionary reasons," it said in a statement.

    "The cause is signals of an increased risk of side effects such as
myocarditis and pericarditis. However, the risk of being affected is
very small."

But the Swedes aren't limiting use of all the mRNA jabs. Instead of
the Moderna vaccine, the Swedish health agency says it's going to
recommend the Pfizer jab for people in this age range instead, as
those in the age range who have already received one Moderna jab will
not be receiving a second (it's not clear whether they will be
receiving a dose of Pfizer instead).

The EMA, the EU's medicines regulator, first approved the Pfizer jab
for young people back in May, while the Moderna jab was approved for
children over 12 in July.

The news sent Moderna shares even lower in premarket trade.

Generally speaking, the EMA, along with local European health
authorities, have been far more cautious about approving vaccines than
their American counterparts, and have also imposed more restrictions
related to age.

The news will likely prompt other Scandinavian health authorities to
review their stance on Moderna and other jabs. After the
announcements, shares of Moderna turned even lower premarket.






US Investigates Moderna Jab After Data Show 2.5x Higher Risk Of Heart
Inflammation

The Internet's social-media censors have been extremely vigilant at
suppressing every tidbit of COVID vaccine "misinformation" that comes
their way. So, as readers might imagine, drawing attention to publicly
released data about the rare (but sometimes deadly) side effects
associated with both mRNA and adenovirus-vector jabs has been...a
challenge.

    Hey @jack what happens to all those who were banned for warning
about this?https://t.co/E9mFoFLqGS
    — zerohedge (@zerohedge) August 20, 2021

But let's back up: over the past couple of months, health authorities
in the US and Israel connected rare instances of myocarditis - that
is, inflammation of the heart - to the mRNA jabs produced by Pfizer
and Moderna. After a hurried secret meeting with its advisors in late
June, the FDA reluctantly released a warning about a "likely
association" between incidences of myocarditis and the new side
effects.

And now, a new twist: On Thursday evening, the Washington Post
published a report claiming that the Moderna coronavirus vaccine may
be associated with a higher risk of myocarditis in younger adults than
previously believed. The report relies on new data from a Canadian
study that has yet to be released.

How much more dangerous is the Moderna jab than the Pfizer? Well, the
preliminary data leaked to WaPo show the risk of myocarditis might be
as much as 2.5x higher for the Moderna jab.

The news represents the latest bump in the road for Moderna's
high-flying stock, as patients (especially younger men in their 20s
and 30s deemed at highest risk to suffer the side effect) now have an
incentive to prefer Pfizer's jab over Moderna's (if they still have
any confidence in the mRNA jabs at all, that is).

WaPo's sources stressed that the new research hasn't yet been
concluded, and that there's still plenty of work to be done before the
FDA decides whether to attach another warning label to the Moderna
jabs. The sources also claimed that the new data "are not slam bang".

    The investigation, which involves the Food and Drug Administration
and the Centers for Disease Control and Prevention, is focusing on
Canadian data that suggests the Moderna vaccine may carry a higher
risk for young people than the Pfizer-BioNTech vaccine, especially for
males below the age of 30 or so. The authorities also are scrutinizing
data from the United States to try to determine whether there is
evidence of an increased risk from Moderna in the U.S. population.

    The two people who described the investigation spoke on the
condition of anonymity to discuss an ongoing review because they were
not authorized to discuss it.

    One of the people familiar with the review emphasized it is too
early to reach a conclusion. The person said the agencies must do
additional work before deciding whether to issue any kind of new or
revised warning or recommendation about the situation. In June, the
FDA added a warning label for the Pfizer and Moderna shots — both
known as mRNA vaccines — about increased risk of myocarditis.

    “We have not come to a conclusion on this,” one of the people
familiar with the investigation said. “The data are not slam bang.”

The FDA and CDC both said they're looking into the data. To be sure,
WaPo notes that the side effects remain "extremely rare" - or at least
"very uncommon." Probably...

    The myocarditis side effect is extremely rare and even if it is
more likely in people receiving the Moderna vaccine, it probably is
still very uncommon. Officials want to be careful not to cause alarm
among the public, especially when officials are trying to persuade
more people to be vaccinated amid a surge of cases fueled by the
fast-moving delta variant.

So far, the FDA and CDC's official position is that the threat posed
by COVID is far worse than any threat posed by vaccine side effects,
and that all Americans over the age of 12 should get the jab. But as
with any recent scientific judgment, there are others in the community
who disagree - some who believe that the risk of side effects for
young people might just outweigh the risk of harm from contracting
COVID, which - as we have reviewed before - is virtually nil.

    “There might be a 2.5 times higher incidence of myocarditis in
those who get the Moderna vaccine compared with Pfizer's vaccine.” Any
risk at all for young people under 17 is unacceptable
https://t.co/vz1REfaaj8
    — Sue Cook (@SueC00K) August 20, 2021





Israel Spots Probable Link Between Pfizer Vaccine, Myocarditis

According to Reuters, Israel's Health Ministry released a statement
Tuesday describing how Pfizer Inc. and BioNTech SE's COVID-19 vaccine
could be linked to dozens of heart inflammation cases, mainly observed
in younger men.

So far, the vaccine has been administered to 5 million people in the
country and could soon be expanded to teens as young as 12-15 years
old.

The ministry's findings found 275 cases of myocarditis between
December 2020 and May 2021, including 148 cases within a month after
the first vaccination. Of these, 27 cases after the first dose and 121
after the second. Half of the people had previous medical conditions.

According to the findings, most patients who experienced heart
inflammation spent less than four days in the hospital, and 95% of the
cases were classified as mild.

The study found "there is a probable link between receiving the second
dose (of Pfizer) vaccine and the appearance of myocarditis among men
aged 16 to 30."

Pfizer said in a statement that it had reviewed the Israeli
observations of myocarditis, noting that no link to its vaccine has
been confirmed.

    "A careful assessment of the reports is ongoing and it has not
been concluded," Pfizer said. "Adverse events, including myocarditis
and pericarditis, are being regularly and thoroughly reviewed by the
companies as well as by regulatory authorities."

Meanwhile, Nachman Ash, Israel's pandemic-response coordinator, told
local radio station Radio 103 FM, "the health committee gave the green
light for vaccinating 12- to 15-year-olds, and this will be possible
as of next week."

An advisory group with the U.S. Centers for Disease Control and
Prevention recommended last month further examination into the
possible link between myocarditis and mRNA vaccines.

The handful of myocarditis cases seem to outweigh the positives as
more than 55% of Israel's population has already been vaccinated.

While the country continues a vaccination spree, what's not being
widely spoken about is a new study that suggests natural immunity to
the virus could last a lifetime.




New Study Links "Acute Chest Pain" In Male Soldiers To mRNA Vaccines

More research has been published highlighting more problematic side
effects linked to COVID-19 shots. Last week, we published our latest
update on rare cases of heart inflammation that have been linked to
the mRNA COVID jabs, including the jabs from Pfizer-BioNTech and
Moderna. After a hurried secret meeting with its advisory board on
vaccine safety, the FDA reluctantly release a warning asking patients
experiencing these symptoms to seek help immediately.

The latest study, published in JAMA's Cardiology Journal on Tuesday,
showed that 23 male soldiers (including 22 who were deemed "previously
health") between the ages of 20 and 51 presented "acute onset of
marked chest pain" within four days of receiving their second dose.
Patients who sought care for chest pain in the military health-care
system following COVID-19 vaccination and were subsequently diagnosed
with clinical myocarditis were included in the case study.

All the members who tested for myocarditis (for those who aren't
familiar with it, myocarditis is a condition that causes the swelling
of the heart muscle and can cause difficulty breathing, heart failure,
and death) were all "physically fit by military standards and lacking
any known history of cardiac disease, significant cardiac risk
factors, or exposure to cardiotoxic agents."

All of the patients whose data was included in the study underwent
electrocardiography and echocardiography tests. Abnormal
electrocardiography findings were recorded in 19 patients (83%):
findings included ST-segment elevations, T-wave inversions, and
nonspecific ST changes. Echocardiography in 4 patients (17%)
demonstrated reduced left ventricular ejection fractions (40% to 50%).

The cardiac symptoms faded within a week of onset for 16 patients,
while 7 others continued to have chest discomfort at the time of this
report; follow-up is ongoing.

As one table from the study showed, the number of cases of heart
inflammation reported in the military is much higher than the rate
that one might expect given population-wide incidence of these
symptoms. This suggests some new variable is likely causing the surge
in cases.

The study's authors concluded that while the overall risk for patients
who received an mRNA vaccine remains extremely small, the US isn't
alone in discovering these cases. Israel, which also relied on mostly
on mRNA vaccines to  inoculate its population, is also seeing
surprisingly high incidence of heart inflammation that's likely linked
to the vaccines.






FDA Adds Warning About Heart Inflammation To COVID-19 mRNA Vaccines

The U.S. Food and Drug Administration (FDA) added a warning about the
risk of developing heart inflammation to information about the Moderna
and Pfizer COVID-19 vaccines.
A young woman receives a COVID-19 vaccine

The FDA announced earlier this month that it would add the warning
after the Centers for Disease Control and Prevention (CDC) had
reported that more cases of heart inflammation—either myocarditis or
pericarditis—were found in young adults and children after they
received the vaccines, which use mRNA technology.

On June 25, the agency said that it would add revisions to its patient
and provider fact sheets about the “increased risks of myocarditis
(inflammation of the heart muscle) and pericarditis (inflammation of
the tissue surrounding the heart) following vaccination” using the
Pfizer or Moderna COVID-19 shots. The Pfizer or Moderna vaccines use
mRNA technology and require two doses, whereas the vaccine made by
Johnson & Johnson uses an adenovirus and requires a single dose.

    FDA Revises Vaccine Fact Sheets to Add Warning on Heart Risks

    Dear twitter time to ban the FDA
    — zerohedge (@zerohedge) June 26, 2021

Still, health officials have said that the risks of developing heart
inflammation are outweighed by the vaccine’s benefits.

“The risk of myocarditis and pericarditis appears to be very low given
the number of vaccine doses that have been administered,” Janet
Woodcock, the acting FDA commissioner, said in a statement last week.
“The benefits of COVID-19 vaccination continue to outweigh the risks,
given the risk of COVID-19 diseases and related, potentially severe,
complications.”

The warning issued by the FDA says that there may be increased risks
“particularly following the second dose and with [the] onset of
symptoms within a few days after vaccination.”

“Additionally, the Fact Sheets for Recipients and Caregivers for these
vaccines note that vaccine recipients should seek medical attention
right away if they have chest pain, shortness of breath, or feelings
of having a fast-beating, fluttering, or pounding heart after
vaccination,” the agency said. “The FDA and CDC are monitoring the
reports, collecting more information, and will follow-up to assess
longer-term outcomes over several months.”

COVID-19 is the disease caused by the CCP (Chinese Communist Party) virus.

There have been more than 1,200 cases of pericarditis or myocarditis
in individuals who are aged 30 or younger who have received the
vaccine doses, according to the latest CDC findings last week.

The case rate, based on submissions to the FDA- and CDC-operated
Vaccine Adverse Event Reporting System, is higher than expected in
young males.

For males between the ages of 12 and 17, the expected number of cases
of heart inflammation following dose one using a 21-day window were
two to 21. The observed number of cases was 32 through June 11. For
males between the age of 18 and 24, the expected number of cases using
the same parameters were three to 34. The observed number of cases was
47.

Representatives for Pfizer and Moderna didn’t respond to requests for
comment by press time.